Sarah Butts

Sarah Butts is a Clinical Program Manager at REVOLUTION Medicines since March 2023, with significant experience in clinical trials and mental health. Previously, Sarah served as a Clinical Trial Leader at MAPS Public Benefit Corporation, managing phase I and II trials for MDMA-Assisted Therapy to address mental health disorders. At Emergent BioSolutions, Sarah held roles as a Clinical Trial Manager and a Clinical Trial Associate Specialist, overseeing vaccine and immunotherapy studies. Sarah’s academic background includes a position as Clinical Research Coordinator and Laboratory Manager at Purdue University, where research focused on nutrient absorption in obesity-related diseases. Early in their career, Sarah worked as a Neurobiology Research Assistant and a Mental Health Case Manager, accumulating a broad range of skills in clinical research and patient support.